You have 2 remaining free articles this month
Try unlimited digital access
link your account for free access. Start here
July 31, 2013 at 12:40 PM EDT
Cubist To Buy Trius And Optimer
Cubist Pharmaceuticals Inc. (Nasdaq: CBST) will pay a premium of approximately $1.6 billion to acquire Trius Therapeutics Inc. (Nasdaq: TSRX) and Optimer Pharmaceuticals Inc. (Nasdaq: OPTR). Shares of Cubist soared $5.60 to $62.60 while Trius stock leaped $2.04 to $13.75. Optimer stock lost 66 cents to $12.63.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here